title: [Rheumatology update--II. Overview of the clinically important status of knowledge and prospects for possible relevant trends in etiopathogenetic research, diagnostic methods and therapeutic possibilities].
authors.affiliation: Klinik für Innere Medizin IV, Friedrich-Schiller-Universität Jena.
authors.forename: G
authors.initials: G
authors.lastname: Hein
authors.forename: R
authors.initials: R
authors.lastname: Bolwin
authors.forename: R
authors.initials: R
authors.lastname: Bräuer
authors.forename: T
authors.initials: T
authors.lastname: Eidner
authors.forename: S
authors.initials: S
authors.lastname: Franke
authors.forename: P
authors.initials: P
authors.lastname: Oelzner
authors.forename: H
authors.initials: H
authors.lastname: Sprott
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D013583:Synovial Membrane / Q000276:immunology
chemical_list: D018501:Antirheumatic Agents
vernacular_title: Update Rheumatologie--Teil II. Resümee des klinisch bedeutsamen Kenntnisstandes und Ausblick auf perspektivisch relevante Trends in ätiopathogenetischer Forschung, diagnostischen Methoden und therapeutischen Möglichkeiten.